Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · IEX Real-Time Price · USD
21.77
-0.01 (-0.05%)
Jul 6, 2022 9:48 AM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Revenue
19.1400
Cost of Revenue
1.900
Gross Profit
17.2400
Selling, General & Admin
59.2222.6911.75
Research & Development
131.4381.6142.99
Operating Expenses
190.65104.354.74
Operating Income
-173.41-104.3-54.74
Interest Expense / Income
17.590.340
Other Expense / Income
-107.05-1.37-2.21
Pretax Income
-83.95-103.26-52.53
Income Tax
0.040.010.02
Net Income
-83.99-103.27-52.55
Net Income Common
-83.99-103.27-52.55
Shares Outstanding (Basic)
302511
Shares Outstanding (Diluted)
302511
Shares Change
20.08%119.84%-
EPS (Basic)
-2.77-4.09-4.58
EPS (Diluted)
-2.77-4.09-4.58
Free Cash Flow Per Share
-1.44-3.54-3.45
Gross Margin
90.06%--
Operating Margin
-906.12%--
Profit Margin
-438.86%--
Free Cash Flow Margin
-228.77%--
Effective Tax Rate
-0.04%-0.01%-0.04%
EBITDA
-65.39-102.31-52.21
EBITDA Margin
-341.65%--
Depreciation & Amortization
0.980.620.32
EBIT
-66.36-102.93-52.53
EBIT Margin
-346.75%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).